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Edited by Lev KisselevAbstract The cis-acting element of structure-anchored repres-
sion (CAESAR) is a post-transcriptional regulatory element of
gene expression, which is located in the 3 0-untranslated region
(UTR) of the human ccn2 gene (ctgf/ccn2). In this report, the
repression mechanism of CAESAR, as well as the structural
requirement, was investigated. Removal of minor stem-loops
from CAESAR resulted in proportional attenuation of the
repressive function, whereas removal of the single bulge or mod-
iﬁcation of primary nucleotide sequence did not aﬀect its func-
tionality. In light of functional mechanism, CAESAR exerted
no signiﬁcant eﬀects on stability or nuclear export of the cis-
linked mRNA. However, this element signiﬁcantly interfered
with the association of such mRNA on ribosome and slowed
down the translation process thereafter in vitro. A translation
repression mechanism by RNA secondary structure to determine
the basal ctgf/ccn2 expression level was uncovered herein.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The connective tissue growth factor (CTGF/CCN2) gene is
one of the prototypic members of the CCN family [1–6].
Namely, the abbreviation ‘‘CCN’’ stands for the assemblage
of the names of the classical members, i.e., ctgf, cyr 61, and
nov [1–6]. Currently, the CCN family includes such members
as ctgf-3/ctgf-L/wisp-2, wisp-1/elm 1, and wisp-3 [2–6]. The gene
products of these members are characterized by a number of
conserved cysteine residues and a common modular structure
consisting of four independent modules that are encoded by
independent exons [1]. In terms of protein function, these mod-
ules are believed to play multiple roles under the interactions
with other regulatory molecules to enable diverse functions.
Such characteristics of CCN family proteins are best repre-
sented by CTGF/CCN2. Early studies on this factor disclosed
its mitogenic and chemotactic activities for ﬁbroblasts [7],
which also provided a rational basis for the role of CTGF/*Corresponding author. Fax: +81 86 235 6649.
E-mail address: takigawa@md.okayama-u.ac.jp (M. Takigawa).
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malignancies of several diﬀerent tissues [8–10]. The physiolog-
ical roles of CTGF/CCN2 are quite well clariﬁed in cartilage
tissues. After the re-discovery of CTGF/CCN2 as a speciﬁc
gene product of the human chondrocytic cell line HCS-2/8
[11], we obtained a series of data deﬁning CTGF/CCN2 as a
central growth factor involved in the growth and diﬀerentia-
tion of chondrocytes [12–14], osteoblasts [15] and vascular
endothelial cells [16,17]. These ﬁndings were supported by
the defect observed in the growth plate of CTGF/CCN2
knockout mice [18]. Role of CTGF/CCN2 in cell adhesion in
collaboration with integrin molecules has been also indicated
[2,19].
Immediately downstream of the open reading frame, a
1 kb-long 3 0-untranslated region (UTR) follows in the ctgf/
ccn2 mRNA. It is widely known that, in a number of eukary-
otic genes, 3 0-UTRs are engaged in the post-transcriptional
regulation of gene expression. Interestingly, we also found
that the 3 0-UTR of CTGF/CCN2 contained a cis-acting ele-
ment of structure-anchored repression (CAESAR). CAESAR
is a post-transcriptional repressive element located at the very
junction of the coding region and 3 0-UTR of the CTGF/
CCN2 gene [20]. It is an 84-base-long mRNA segment that
forms a stable secondary structure. When linked within a
transcribed region of a gene in cis, CAESAR strongly inhibits
its expression. However, precise structural requirement and
mechanism of repressive action have remained to be clariﬁed.
Here, we further investigated the structural–functional rela-
tionship and the functional properties of CAESAR as a
post-transcriptional regulatory element. Based on the ob-
tained ﬁndings, we consider CAESAR as an RNA transla-
tional repressor that functions through the recognition of
secondary structure to determine the basal level of ctgf/ccn2
expression.2. Materials and methods
2.1. Cells
Cos-7 (a monkey kidney cell line), MDA-231 (a human breast cancer
cell line), HSC3 (a human oral squamous cell carcinoma cell line),
HeLa (a human cervical cancer cell line), HCS-2/8 (a human chondro-
sarcoma cell line) and 293T (a human embryonic kidney cell line) cells
were maintained at 37 C in Dulbeccos modiﬁed Eagles minimum
essential medium (D-MEM) supplemented with 10% fetal bovine serum
(FBS) in an atmosphere of humidiﬁed air containing 5% CO2.blished by Elsevier B.V. All rights reserved.
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The SV40 promoter-driven ﬁreﬂy luciferase expression plasmids,
pGL3-control, pGL3L(+) and pGL3L(), were described previously
[20]. An HSV-TK promoter-driven Renilla luciferase expression plas-
mid (pRL-TK; Promega, Madison, WI) was utilized as an internal
control. The original chimeric construct containing the full-length 3 0-
UTR (pGL3UTRS: Fig. 1) or the intact CAESAR (pGL3SA5) at
the downstream end of the luciferase gene was constructed as described
previously [20].
2.3. CAESAR mutant constructs
Among the mutants analyzed, pGL3E23 and GCAESAR were de-
scribed previously [20]. To remove the central bulge in the secondary
structure, two oligonucleotides, E3BP (5 0-AATTCGAACTGATT-
CACTCTCATTTTTCCG-3 0) and E3BM (5 0-CGGAAAAATGA-
GAGTGAATCAGTTCG-3 0) were annealed to each other, and
ligated between the internal EcoRI and external EcoRV sites of
pGL3E23, replacing the latter half of the CAESAR region. The resul-
tant plasmid was designated pGL3E23DB. The other two mutants
were designed to remove 1 or 2 minor stem-loops of CAESAR. For





















































Fig. 1. (A) The repressive eﬀects of the 3 0-UTR of human ctgf/ccn2 on gen
constructs used for the evaluation are shown at the top. Small box below the
Abbreviations: SVp, SV40 promoter; poly A, SV40 polyadenylation signal
element of structure-anchored repression. The results of evaluation are show
control with error bars (standard deviations). Names of the cells used are indi
(B) Repressive activities of the entire 3 0-UTR and CAESAR in Cos-7 cel
experiments. (C) Nucleotide sequence and predicted secondary structure of[20], was utilized. The chimeric plasmid containing DML1 was con-
structed by the addition of the annealed short oligonucleotides (5 0-
CTAGCGGAAA-3 0 and 5 0-CTGATTTCCG-3 0) at the XbaI site of
pGL3E12 to retrieve the major stem but not the ﬁrst minor loop. Fi-
nally, in order to construct a CAESAR mutant lacking both minor
loops, STEMP (5 0-CTAGACGGAGAAATGAGATGTGAATTA-
GACTGG-30) and STEMM (5 0-AATTCCAGTCTAATTCACATCT-
CATTTCTCCGT-3 0) were synthesized and replaced the former-half of
the CAESAR region between the XbaI and internal EcoRI sites in
pGL3E23. The resultant plasmid was designated as pGL3E23DTL.
The E2 mutant that contained only the upper half of the predicted
structure was an E23 derivative, in which the lower half was removed.
2.4. Plasmids for in vitro transcription
A control plasmid, pBSLuc, was obtained by subcloning the
1.85 kbpHindIII–HpaI fragment, which comprises the entire luciferase
coding region and a portion of polyadenylation signal region of pGL3-
control, between the unique HindIII and SmaI sites in pBluescript
SK() (Stratagene). Following the same construction procedure, the
corresponding HindIII–HpaI fragment from pGL3SA5 was built in









e expression in a variety of primate cells. Structures of the molecular
illustration indicates approximate location of CAESAR in the 3 0-UTR.
; 3 0-UTR, human ctgf/ccn2 3 0-UTR cDNA; CAESAR, the cis-acting
n in percentages as relative activities from the UTR construct versus
cated in horizontal axis. Origins of these cells are described in Section 2.
































Fig. 2. Structure-targeted mutational analysis of CAESAR. Nucleotide sequences and possible secondary structures of CAESAR mutants are
displayed, together with their repressive activities as measured by the luciferase assay system at the bottom. Mutated nucleotides in E23 or G and C
bases in GCAESAR are indicated in boldface, respectively. The results are demonstrated in the same manner as in Fig. 1.
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HincII and self-religated to remove the 1.28-kbp major portion of
the luciferase-coding region. The resultant plasmid, pBS ÆLuc (Fig.3), contained a 0.35-kbp gene fragment encoding the carboxy terminus
of the luciferase followed by a 0.16-kbp sequence from pGL3-control
as an external insert.
Fig. 3. (A) Schematic representation of the preparation of the
riboprobe and putative protected probe fragments expected in the
ribonuclease protection analysis. Origins of each fragment of pBS ÆLuc
are indicated; pBlue: pBluescript SK(). Polyadenyl tails and struc-
tured CAESAR are schematically illustrated. An open box designated
‘‘pA’’ indicates, not polyadenyl tails, but a small fragment of
polyadenylation signal from the parental plasmid. (B) Subcellular
fractionation of RNA. Total RNA was extracted from Cos-7 cells that
had been transfected with pGL3-control (C) or pGL3SA5 (SA5). Note
that 45s ribosomal RNA precursor is totally absent in the cytoplasmic
fraction (Cyto), whereas it is abundantly seen in the nuclear fraction.
(C) Ribonuclease protection analysis of the RNAs in panel B with the
riboprobe shown in panel A. The 570-bp free probe and another chain-
length RNA marker of 120 bases were loaded as chain-length
standards. Abbreviations in this panel represent the same as in panel B.
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by automated DNA sequencing (Applied Biosystems/Perkin–Elmer,
Foster City, CA).
2.5. DNA transfection
Twenty hours prior to transfection, cells were seeded into 35 mm tis-
sue culture dishes or 12-well tissue culture clusters. Cationic liposome-
mediated DNA transfection was performed with each pGL3 derivative
in combination with 0.5 lg of pRL-TK (internal control), according to
the manufacturers optimized methodology (LipofectAMINE; Life-
technologies, Rockville, MD: Fugene; Roche Diagnostics, Mannheim,
Germany). Forty-eight hours after transfection, the cells were lysed
and forwarded to the luciferase assay.
For RNA analysis, transfection was carried out at an expanded scale
in a 10 cm diameter tissue culture dish with 1.6 · 106 cells and 8 lg of
each pGL3 derivative. Isolation of ribosomal complex was carried out,
using transfected cells at an expanded scale with two 10 cm diameter
dishes per sample.
2.6. Luciferase assay
The Dual Luciferase system (Promega) was applied for the sequen-
tial measurement of ﬁreﬂy and Renilla luciferase activities with speciﬁc
substrates of beetle luciferin and coelenterazine, respectively [20]. Cell
lysates were diluted appropriately to give an accurate measurement
within the linear range.
2.7. RNA subcellular fractionation
Forty-eight hours after transfection, cells were washed and
harvested in 5 mM EDTA/phosphate-buﬀered saline (PBS). Cell
membrane was lysed by incubation on ice for 5 min in an RNex buﬀer(0.14 M NaCl, 1.5 mM MgCl2, 10 mM Tris–HCl, 0.5% Nonidet P40,
1 mM DTT, 20 mM vanadyl ribonucleoside complex). The cell nuclei
were pelleted by centrifugation and lysed for RNA extraction in a com-
mercially available reagent (Trizol: Lifetechnologies, Rockville, MD).
The cytoplasmic fraction was treated by proteinase K and the RNA
was recollected by 2-propanol precipitation after phenol–chloro-
form–isoamylalcohol extraction, as described previously [21].
2.8. Riboprobe preparation and ribonuclease protection analysis
The riboprobe was transcribed in vitro by bacteriophage T3 or T7
RNA polymerase in the presence of [a-32P] UTP (Dupont/NEN, Bos-
ton, MA). The transcription template, pBLDLuc was linearized by
HincII prior to transcription. Twenty micrograms of total RNA was
hybridized with 7 · 105 cpm of radiolabeled probe in a hybridization
buﬀer containing 80% formamide at 42 C for 20 h. After hybridiza-
tion, the RNA mixture was digested by a cocktail of RNase T1 and
RNase A at 30 C for 40 min, as described previously [22,23]. The di-
gested mixture was analyzed by 6% PAGE under denaturing condi-
tions in 1 · Tris–borate–EDTA (TBE) buﬀer. Quantitatively of the
assay system was ascertained by the fact that signal intensity of the
strongest protected band was less than 10% of that of the total input
probe.
2.9. Ribosomal sedimentation
Brief summary of the procedure is illustrated in Fig. 4A. The trans-
fected 293T cells (3.2 · 106) were washed with PBS and suspended in
1 ml of Buﬀer A (0.25 M sucrose, 25 mM KCl, 5 mM MgCl2, 2 mM
dithiothreitol, 50 mM Tris–HCl, pH 7.4). Cytoplasmic membrane
was lysed by the addition of NP-40 at a ﬁnal concentration of
0.7%, and the nuclei were pelleted down by a centrifugation at
750 · g. After the removal of the nuclei, the supernatant was further
centrifuged at 12500 · g to remove mitochondria. The supernatant
containing ribosome was supplemented to contain 0.5 M KCl and
loaded onto a 1 M sucrose cushion in a ultracentrifuge tube. Final
centrifugation was performed at 245000 · g for 10 h. The ribosome-
associated RNA was then extracted by the same procedure as de-
scribed above.
2.10. In vitro translation assay
Preparation of luciferase RNA with or without CAESAR was per-
formed in vitro with pBSLuc, or pBSLucSA5, respectively, as a tem-
plate. The template plasmid was linearized by BamHI digestion (Fig.
5), and 1 lg of DNA was forwarded to in vitro transcription reaction
under the same reaction and puriﬁcation procedure as used for the
riboprobe.
In vitro translation analysis was carried out in a 30 ll volume that
contained 21 ll of nuclease-treated rabbit reticulocyte lysate (Prome-
ga) supplemented with a total amino acid mixture. To start the reac-
tion, 21 ll of the supplemented reticulocyte lysate was mixed with
50 ng of RNA in 9 ll of H2O. After 10 and 20 min of incubation at
37 C, 5 ll out of 30 ll-translation mixture was forwarded to the ﬁreﬂy
luciferase assay, as described elsewhere.
2.11. Reverse-transcription and real-time quantitative polymerase chain
reaction (PCR) analysis of mRNA
Polyadenylated RNAs were selectively reverse-transcribed at 50 C
for 30 min from 500 ng of each total RNA by using an avian mye-
loblastosis virus reverse-transcriptase (AMV-RT: Promega) and an
oligo(dT) octadecamer. The copy numbers of ﬁreﬂy luciferase
mRNA were evaluated by real-time PCR with a Lightcycler system
(Roche Diagnostics). The nucleotide sequences of the primers as
follows: Luc-LCS (sense), 5 0-CCGCCTGAAGTCTCTGATTA-30;
Luc-LCA (anti-sense), 5 0-TCCACAAACACAACTCCTCC-3 0. The
ampliﬁcation procedure under the optimized protocol consisted of
a denaturation at 95 C for 15 min, 45 cycles of ampliﬁcation reac-
tions at 95 C for 15 s, 64 C for 10 s, and 72 C for 10 s. Identity
of all of the PCR products was conﬁrmed by analyzing the melting
curves.
2.12. Secondary structure prediction of RNA segments
Computer-associated prediction of putative RNA secondary struc-
ture was performed with a software program (GENETYX ver. 8.0:
Software Development Co. Ltd., Tokyo, Japan).
Fig. 4. Translational interference by cis-linked CAESAR. (A) A summary of subcellular fractionation procedure to obtain ribosome-associated
mRNA is illustrated. (B) Quantitative analysis of ribosome-associated reporter mRNA. Total RNA was extracted from the sedimented ribosome and
subjected to quantitative real-time PCR analysis after reverse transcription. The same reporter constructs shown in Fig. 1 were used for transient
expression of the reporter mRNAs. The results of quantiﬁcation of ribosome-associated luciferase mRNA are displayed. The mRNA copy numbers
in 25 ng of rRNA were computed in reference to the standard samples of control plasmid. The third column marked DP denotes the results with a
luciferase construct without a promoter in the same molecular background. (C) In vitro transcribed cap-free RNAs used in the in vitro translation
experiments. Structures of transcription templates are displayed with the corresponding transcripts. Abbreviations here indicate the same as
described in Fig. 3. (D) Attenuation of cap-free translation by CAESAR. Fireﬂy luciferase activities at 2 time points from the translation mixture
containing either RNA are shown with error bars. Hatched and solid columns represent ﬁreﬂy luciferase activities from Luc and LucSA5 RNAs,
respectively.
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3.1. Universal repressive potential of CAESAR in a variety of
human cell lines
In our previous report, the repressive eﬀects of the 3 0-UTR
was conﬁrmed in few cell lines. In advance to further analysis,
we here evaluated the repressive potential of the human ctgf/
ccn2 3 0-UTR in a variety of human cell lines. In the present
study, a variety of human cell lines were subjected to similar
analysis by means of transient reporter gene expression assay.
As a result, all of the human cell lines of diﬀerent origins –
breast cancer, oral squamous cell carcinoma, cervical cancer
and chondrosarcoma – commonly revealed strong repressive
eﬀects of the 3 0-UTR (Fig. 1). As such, it was indicated that
the 3 0-UTR-mediated repression was quite fundamental mode
of gene regulation to restrain the basal gene expression at low
levels.
In the 3 0-UTR, CAESAR at the upstream end was previ-
ously identiﬁed as a major element that conduct the observed
repressive eﬀects. Of note, in Cos-7 cells, almost all of the
repressive activity could be ascribed to the action by CAESAR
alone, as represented by the comparable eﬀect of CAESAR to
that of the entire 3 0-UTR in this particular cell line. Therefore,
we utilized Cos-7 cells for subsequent structural–functional
dissection of CAESAR.3.2. Structural requirement of CAESAR for the repressive
function
To examine the possible role of the major-loop nucleotide
sequence in the function, we introduced mutations in the CAE-
SAR to obtain E23 mutant. Not only this mutant provided evi-
dence that the primary nucleotide sequence in the major loop
was not a determinant of the function (Fig. 2), but also it
was utilized to construct the other CAESAR mutants to dis-
sect structural requirement of the repressive function. First,
we constructed a CAESAR mutant in which the bulge struc-
ture in the center of CAESAR was removed. Functional eval-
uation of this CAESAR mutant, DB, clearly showed that
CAESAR could be fully functional without the central bulge
(Fig. 2). Together with the entire retention of the repressive
function in a mirror image CAESAR analogue (GCASAR:
Fig. 2) that possess totally unrelated primary nucleotide se-
quence, no primary sequence and the central bulge were found
to be required for the CAESAR function. Next, we pursued
the role of the multiple stem-loop structure in the repressive
function. Initially, we removed a minor loop at the upstream
half of the CAESAR and evaluated the functionality of this
CAESAR mutant, DML1. As a result, DML1 still retained sig-
niﬁcant repression potential, but its functionality was modestly
attenuated. Then, we further removed the other loop and
examined whether the major stem-loop only was suﬃcient
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reporter assay revealed a remarkable reduction in repressive
activity on gene expression. Finally, total removal of the
stem-loop structure resulted in complete loss of the repressive
eﬀect (Fig. 2B). Therefore, the observed gradual loss of the
repressive function along with the sequential removal of minor
loops indicates the requirement of multiple stem-loop structure
as a determinant of CAESAR function.3.3. Nuclear export as well as overall stability of mRNA was not
aﬀected by CAESAR linked in cis
CAESAR has been supposed to function during the process
of nuclear export of mRNA or during the translation events
after the nuclear export. Thus, the former possibility was ini-
tially examined. Fireﬂy luciferase mRNA with or without
CAESAR was expressed in Cos-7 cells, and total RNA was
fractionated into subcellular cytoplasmic and nuclear popula-
tions. Successful fractionation was conﬁrmed by the ﬁndings
that distinct signals for the 45S ribosomal RNA precursor were
observed in the nuclear fraction, which originates from nucleo-
lar RNA, while such a signal was totally absent in the cytosolic
fraction (Fig. 3, panel B). In those fractionated RNAs, the fate
of the luciferase mRNA with/without CAESAR was pursued.
Ribonuclease protection analysis was employed for the
study of both the mRNA quantity and structure around the
CAESAR-addition point. A riboprobe around the CAE-
SAR-addition point at the 3 0-UTR was prepared and utilized.
As summarized in Fig. 3A, the RNA from the pGL3-control
was expected to protect the entire 510-base segment that orig-
inated in pGL3-control. In contrast, the portions of the probe
that would be protected by pGLSA5-derived mRNA were 350-
and 160-base segments, owing to the inserted CAESAR se-
quence. As shown in Fig. 3C, the results were totally consistent
with this prediction. More importantly, the intensities of spe-
ciﬁc signals from either the cytosolic or nuclear fraction
showed no signiﬁcant diﬀerence, regardless of the involvement
of CAESAR (Fig. 3C). Therefore, we concluded that CAE-
SAR did not alter the nuclear export status of cis-linked
mRNA as well as its intracellular stability and that the CAE-
SAR-mediated repression may be mainly conducted by cyto-
plasmic events.3.4. Interference of ribosomal association by cis-linked
CAESAR
After the nuclear export, mature mRNAs have to be assem-
bled onto ribosomal complexes for initiating their translation.
Since several cis-elements in 3 0-UTRs have been known to
control gene expression through this process [24], we investi-
gated the eﬀects of CAESAR on ribosomal association of
the cis-linked reporter mRNA. For this objective, we em-
ployed 293T cell line, which is a human analogue of Cos-7
as a provider of cellular background. We transiently expressed
the same reporter mRNAs as described in the previous subsec-
tion and chased their fate in the cytoplasm. Since 293T is a hu-
man cell line, we could monitor the experiments by verifying
the equivalent level of ribosomal association of an internal
control (b-actin mRNA), which is diﬃcult with monkey
Cos-7 cells. The results of real-time quantitative RT-PCR
analysis of ribosome-associated portion of mRNAs indicated
the interference of ribosomal association by the cis-linked
CAESAR (Fig. 4).3.5. Translational repression by CAESAR at the 3 0-UTR in vitro
As indicated by the results above, CAESAR functions as a
repressor of ribosomal association, which is mostly conducted
by the 5 0-cap-madiated recruitment of mRNAs by eukaryotic
initiation factors. Nevertheless, with the system above, no
information concerning other translation parameters, such as
translation speed after ribosomal assembly, could be obtained.
It is still possible that CAESAR may repress translation at
stages after ribosomal association as well. Therefore, in order
to examine if CAESAR aﬀects mRNA translation after 5 0-
cap-mediatedprimaryassociation,weemployedan invitro rabbit
reticulocyte lysate translation system to evaluate the transla-
tion eﬃciency. Since this system works even with 5 0-cap-free
mRNAs, we could rule out the eﬀects of CAESAR upon the
cap-mediated recruitment of mRNA onto the 43s initiation
complex by eIF-4F. The 5 0-cap-free ﬁreﬂy luciferase RNA with
or without CAESAR at the 3 0-UTR was transcribed in vitro
by bacteriophage T7 RNA polymerase by using corresponding
plasmids as templates (Fig. 4A), and equivalent amounts of
RNAs were subjected to in vitro translation analysis. As a re-
sult, in vitro evaluation of translation eﬃciency of the cap-free
mRNAs under unsaturated conditions revealed signiﬁcant dif-
ference at 20 min. At 10 min, the diﬀerence between the two
was not signiﬁcant, which suggests CAESAR may not exert
any eﬀect on the early steps of such an atypical 5 0-cap-indepen-
dent translation procedure. As such, together with the data
concerning the eﬀects of CAESAR on the ribosomal associa-
tion of intact mRNA, these data indicated that CAESAR
interfered with mRNA translation process at multiple steps.4. Discussion
CAESAR was discovered in the 3 0-UTR of the human ctgf/
ccn2 gene as a major cis-element conferring post-transcrip-
tional repressive eﬀects on gene expression. In this study, com-
prehensive analyses to dissect out the structural–functional
relationship have been carried out. Moreover, we here dis-
closed that the repressive ability of CAESAR is exerted at
the translation procedure.
Post-transcriptional control of gene expression is mostly
conducted by speciﬁc elements on mRNAs, in collaboration
with their speciﬁc binding counterparts. In a number of well-
characterized cases, these RNA elements are known to form
stable secondary structures. Several signal sequences in
eukaryotic mRNAs that enable eﬃcient nuclear export have
been identiﬁed as well. Interestingly, they are all located in
the 3 0-UTR [24,25]. Post-transcriptional cis-elements in 3 0-
UTRs can also determine the fate of certain mRNAs by con-
trolling their degradation [26]. Finally, it has been also known
that certain RNA segments play critical roles in the regulation
of the protein translation process [24]. We initially examined
the eﬀects of CAESAR on mRNA export and stability. How-
ever, neither the nuclear accumulation of the reporter mRNA,
nor a reduction in the steady-state mRNA levels was induced
by cis-addition of CAESAR. Then, we moved forward to eval-
uate whether cis-addition of CAESAR aﬀected ribosomal
association, or not. Usually, ribosomal assembly of particular
mRNAs is evaluated by fractionating cytosolic RNA from free
to polysome-associated RNA through the gradient of sucrose
density by ultracentrifugation. This methodology is excellent
for the analysis of endogenous and viral mRNAs. However,
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to our case with DNA transfection, because of the contamina-
tion of plasmid DNA. We could ﬁnally remove the back-
ground signals by pelleting down only the polysomes
through ultracentrifugation on a sucrose cushion. This ap-
proach was cleaner, but might be less sensitive. Obviously,
the observed interference in this evaluation (Fig. 4B) does
not fully account for the repressive potential by CAESAR in
vivo (Fig. 1B). This discrepancy may be ascribed to the insen-
sitivity of the evaluation system only with polysomal pellets.
Establishment of an alternative expression/analysis method is
currently in progress. Additionally, in order to further dissect
the eﬀect of CAESAR on translation thereafter, we employed
a cap-independent in vitro translation assay system. After all,
we eventually found that cis-linked CAESAR repressed gene
expression by interfering with translation at multiple steps.
Translation control by a cis-element together with its bind-
ing counterparts is best represented in the regulatory system
using Nanos and Pumilio gene products in Drosophila [27].
According to a number of previous reports, these two proteins
bind to a 32 base element in the 3 0-UTR of the mRNA for the
transcription factor Hunchback, to repress its translation [27].
This system is structurally and functionally similar to the
CARSAR-mediated repression system. Under such a system,
Nanos and Pumilio actually play critical roles in conducting
germline development. According to the ﬁndings obtained in
this study, the CAESAR function is assumed to be based on
the recognition of the multiple stem-loop structure without se-
quence speciﬁcity. Therefore, a number of RNA segments with
CAESAR-like elements may well be under the same regulation
conducted by the same cellular counterpart(s). It is noteworthy
that Nanos shows relatively ﬂexible target selectivity.
It is now clear that cis-addition of CAESAR represses the
basal translation level without aﬀecting pre-translational status
of mRNA. However, it is still possible for the built-in CAE-
SAR to alter the half-life of mRNA in response to certain stim-
uli. Such an example is found in the 3 0-UTR of the parathyroid
hormone (PTH) gene [28]. This system is driven by cytosolic
factors that bind speciﬁcally to the structured RNA target in
the 3 0-UTR to control its degradation eﬃcacy [28]. Further-
more, we recently reported this type of dynamic regulation
in chicken ctgf/ccn2 gene, which was actually mediated by
the 3 0-UTR. In this case, ctgf/ccn2 gene expression was duly
regulated along with chondrocytic diﬀerentiation, utilizing a
3 0-UTR-mediated control of mRNA degradation [29]. Exten-
sive investigation to clarify the dynamic roles of CAESAR in
gene control under particular biological process is currently
underway.
CTGF/CCN2 is a key player in endochondral ossiﬁcation, a
process that determines the growth of longitudinal bone [4].
Diﬀerential expression of the ctgf/ccn2 gene is observed in
growth cartilage and other certain tissues during the develop-
ment of vertebrates [4]. Under physiological conditions in
adult animals, a very limited population of the cells has been
shown to express CTGF/CCN2. Therefore, the novel CAE-
SAR-mediated translation repression system clariﬁed here
may be a fundamental component of gene regulatory machin-
ery to determine the basal level of ctgf/ccn2 gene expression.
Since such long 3 0-UTRs are also found in other ccn family
members, this particular mode of 3 0-UTR-mediated regulatory
system may have evolved along with this particular family of
genes encoding proteins with similar structure and function.Comprehensive analysis of all of the CCN family members will
carve out the common origin and nature of these genes and
their translational products.
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